A recent investigation in Ahmedabad has come under scrutiny for overlooking the human cost of illegal trials. The probe, which was conducted to uncover the truth behind illegal drug trials in the city, has been criticized for failing to address the impact on the individuals involved. The investigation, which was prompted by reports of unethical practices in the pharmaceutical industry, focused primarily on the legal and regulatory aspects of the trials. However, critics argue that the real issue lies in the exploitation of vulnerable populations who participate in these trials. The lack of consideration for the human cost of these illegal activities has raised concerns among activists and medical professionals. It is imperative that future investigations take into account the ethical implications of such practices and prioritize the well-being of the individuals affected. The findings of this investigation highlight the need for greater oversight and regulation of drug trials in India to ensure the protection of human rights and ethical standards. As the pharmaceutical industry continues to expand in the country, it is crucial that measures are put in place to prevent the exploitation of vulnerable populations. This incident serves as a reminder of the importance of upholding ethical standards in medical research and the need for transparency and accountability in the pharmaceutical sector.